Compare Align Technology, Inc. (ALGN) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs JPMorgan Chase & Co — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while JPMorgan Chase & Co trades at $337.87 (market cap $901.58B). The key difference: JPMorgan Chase & Co is far larger — about 70.1× Align Technology, Inc.'s market cap, and JPMorgan Chase & Co pays a 1.78% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | JPM | |
|---|---|---|
Market Cap | $12.86B | $901.58B |
Sector | Health | Financials |
52-Week High | $207.19 | $339.22 |
52-Week Low | $124.88 | $282.84 |
Enterprise Value | $11.92B | — |
Volume | — | 10,479,943 |
Dividend Yield | — | 1.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
JPMorgan Chase (JPM) trades at $336.47, up 0.3% with a bullish technical signal. The stock shows strong fundamentals with $181.85B revenue and 31.61% net margin in 2025, though Q4 2025 EPS missed expectations. Analyst consensus is Moderate Buy with a $360.38 price target, representing 7% upside. Recent news highlights CEO Jamie Dimon's economic warnings and upcoming Q1 2026 earnings on April 14.
JPM offers solid investment potential with strong ROE (17.03%) and consistent earnings beats, but faces risks from geopolitical tensions and cybersecurity threats. The current valuation at 16.11 P/E appears reasonable given the bank's market leadership position. Investors should monitor Q2 2026 earnings results for confirmation of growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
